A New Biosimilar for a Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved the third Herceptin (trastuzumab) biosimilar to treat certain types of cancer.
New Biosimilar Gets Green Light
The US Food and Drug Administration (FDA) has approved a new biosimilar.
FDA Approves Combo Treatment for Stomach, GE Junction Adenocarcinoma
The US Food and Drug Administration (FDA) today approved a new combination treatment for patients with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma.
High Blood Glucose Levels Associated With Cancer
Having too much sugar in your blood, even if you are not diabetic, is considered unhealthy. And there may be an association between having high blood sugar levels and developing a serious health condition.
Aspirin May Decrease Cancer Risk
Aspirin is one of the cheapest and most common medicines available. Regular use of aspirin has been linked to lower risk of heart problems, but it may also help prevent other serious conditions.
New Stomach Cancer Rx Approved
Some stomach cancer patients who have gone through chemotherapy but still have not recovered from their condition may now have a new treatment option.
FDA Approves New Rx for Stomach Cancer
The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach.
Stomach Surgery for Improved Cancer Survival
Patients who have advanced stomach cancer sometimes choose stomach surgery to relieve bleeding and other painful symptoms. That operation may also prolong their lives.
Weighing in on Teen Cancer Risks
Obesity in adults is linked to increased risks of esophageal cancer, a nasty disease that’s on the rise in the US, Europe and Israel. Researchers have now discovered that being overweight earlier in life may also influence cancer risks.
Stomach Cancer Has New Foe
It’s always exciting when clinical trials show positive results for a new cancer treatment. An international phase lll trial did just that.